One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Dysphagia in Dermatomyositis Due to Esophageal Adenocarcinoma
JuneTome∗Amrit K.Kamboj‡Cadman L.Leggett‡
Immune-Mediated Colitis Induced by Pembrolizumab
HiroakiSaito∗KanaOno‡Jun-ichiAkahira§
Three Signs of Pneumoperitoneum on a Supine Radiograph
AkiraHokama∗SatomiYara‡JiroFujita‡
Hepatic Sinusoidal Obstruction Syndrome Post-Liver Transplantation: A Rare Complication of Tacrolimus
ChangLi∗HanyuMa‡CanhuiSun∗
Duodenal Penetration by Inferior Vena Cava Filter Placement
TsubasaYamaguchiMegumiTakagiToshiyukiMorisawa
Casal’s Necklace: Extraintestinal Manifestation of Tropical Sprue
Sukrit SinghSethiSanjeevSachdevaAmarender SinghPuri
Colonic Granular Cell Tumor With Ileocecal Valve Involvement
PhilipKozan∗SittipornBencharit‡DannyIssa‡
Primary Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient with Primary Biliary Cholangitis
KensukeHamadaShujiYamamotoHiroshiSeno
Health Policy Priorities for the Biden Administration
MarkJapingaMPAff∗AnnaBartzBA‡RobertSaundersPhD∗MarkMcClellanMD, PhD∗
Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide
LucasGuillo∗‡ChristianRabaud§Ernest H.Choy||FerdinandoD’Amico‡¶SilvioDanese¶#Siew C.Ng∗∗LaurentPeyrin-Biroulet‡
AGA Clinical Practice Update on Management of Medically Refractory Gastroparesis: Expert Review
Brian E.Lacy∗JanTack‡C. PrakashGyawali§
Emerging Role of Transnasal Endoscopy in Children and Adults
NathalieNguyen∗‡JacobMark∗‡Glenn T.Furuta∗‡
The Weighty Issue of Treating Obesity in Patients With Nonalcoholic Fatty Liver Disease
Leon A.AdamsMBBS
The Transition From Rome III to Rome IV Irritable Bowel Syndrome: What We Gain and Lose
AndreaShinMD, MScLinChangMD
Block, Blood, or Both? Outcomes, Opportunities, and Barriers in Colorectal Cancer Universal Testing
Sonia S.KupferMD
Ascending the Staircase of Periendoscopic Anticoagulant Knowledge
Neena S.AbrahamMD, MSCEKimberlyHuynhBSc
Is It Time to Abandon Gastric Emptying in Patients With Symptoms of Gastroparesis and Functional Dyspepsia?
Reena V.ChokshiMDLinChangMD
Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
PichamolJirapinyo∗‡Thomas R.McCarty∗‡Russell D.Dolan∗‡RajShah§Christopher C.Thompson∗‡
Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
WaseemAhmedMD∗JonathanGalatiMD‡AnandKumarMD∗§Paul J.ChristosDrPH, MS||RandyLongmanMD, PhD∗Dana J.LukinMD, PhD∗EllenScherlMD∗RobertBattatMD∗
Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results From a Phase 3 Trial
IkuoHirano∗Margaret H.Collins‡David A.Katzka§Vincent A.Mukkada‖Gary W.Falk¶RobinMorey#Nirav K.Desai∗∗LanLan#JamesWilliams∗∗Evan S.Dellon‡‡ORBIT1/SHP621-301 Investigators
Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab
Evan S.Dellon∗NirmalaGonsalves‡Marc E.Rothenberg§IkuoHirano‡MirnaChehade||Kathryn A.Peterson¶Gary W.Falk#Joseph A.Murray∗∗Lauren T.Gehman‡‡Alan T.Chang‡‡BhupinderSingh‡‡Henrik S.Rasmussen‡‡Robert M.Genta§§
Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit
Henry P.Parkman∗EmilySharkey‡Richard W.McCallum§William L.Hasler‖Kenneth L.Koch¶IreneSarosiek§Thomas L.Abell#BradenKuo∗∗Robert J.Shulman‡‡MadhusudanGrover§§GianricoFarrugia§§RonSchey∗JamesTonascia‡FrankHamilton‖‖Pankaj J.Pasricha‡NIH/NIDDK Gastroparesis Consortium
Patient Satisfaction of Propofol Versus Midazolam and Fentanyl Sedation During Colonoscopy in Inflammatory Bowel Disease
CasperSteenholdt∗aJeppe T.Jensen∗aJørnBrynskov∗Ann MereteMøller‡Anne ChristineLimschou∗LarsKonge§PeterVilmann∗
Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study
Vivek C.Goodoory∗‡Lesley A.Houghton∗YanYiannakou§Christopher J.Black∗‡bAlexander C.Ford∗‡b
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial
William J.Sandborn∗RoryRebuck‡YuhuaWang‡BinZou‡Omoniyi J.Adedokun‡ChristopherGasink§Bruce E.Sands||Stephen B.Hanauer¶StephanTargan#SubrataGhosh∗∗Willem J.S.de Villiers‡‡Jean-FredericColombel||Brian G.Feagan§§John P.Lynch‡
Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status
William J.Sandborn∗LaurentPeyrin-Biroulet‡Ala I.Sharara§ChinyuSu||IreneModesto¶RajivMundayat¶L. MertGunay#LeonardoSalese||Bruce E.Sands∗∗
Lubiprostone for Pediatric Functional Constipation: Randomized, Controlled, Double-Blind Study With Long-term Extension
Marc A.Benninga∗Sunny Z.Hussain‡Manu R.Sood§SamuelNurko||PaulHyman¶†Robert A.Clifford#MollyO’Gorman∗∗TarynLosch-Beridon‡‡ShadreckMareya§§PeterLichtlen||||CarloDi Lorenzo¶¶
Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome
AriadnaSánchez∗Victorine H.Roos‡aMatildeNavarro§aMartaPineda§BertaCaballol∗LorenaMoreno∗SabelaCarballal∗LorenaRodrÃguez-Alonso‖TeresaRamon y Cajal¶GemmaLlort#VirginiaPiñol∗∗Adrià López-Fernández‡‡InmaculadaSalces§§Maria DoloresPicó‖‖LauraRivas¶¶LuisBujanda##MartaGarzon∗∗∗AngelesPizarro∗∗∗…FrancescBalaguer∗b
Risk of Colorectal Cancer in Serrated Polyposis Syndrome: A Systematic Review and Meta-analysis
CharlesMuller∗AkihiroYamada‡SachieIkegami§HaiderHaider∗YugaKomaki||FukikoKomaki||DejanMicic∗AtsushiSakuraba∗
Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists
EnriqueRodrÃguez de Santiago∗RubénSánchez Aldehuelo∗FaustoRiu Pons‡§CarlosRodrÃguez Escaja‖GloriaFernández-Esparrach¶#∗∗Ã�ngelCañete-Ruiz‡‡CarlosFerre Aracil§§DanielPérez-Corte‖‖RaquelRÃos León¶¶Héctor MiguelMarcos-Prieto##Pedro G.Delgado-Guillena∗∗∗AnaGarcÃa-RodrÃguez‡‡‡CharlyGuarner-Argente§§§AlfonsoMuriel‖‖‖Elsade la Fuente-Briongos∗AnaGarcÃa GarcÃa de Paredes∗SofÃaParejo-Carbonell∗LuisTéllez∗…MarÃaLópez-Cerón
High-Resolution Manometry Thresholds and Motor Patterns Among Asymptomatic Individuals
ArvindRengarajan∗Benjamin D.Rogers∗ZhiqinWong‡SalvatoreTolone§DanielSifrim||JordiSerra¶EdoardoSavarino#SabineRoman∗∗‡‡§§Jose M.Remes-Troche||||RosaRamos¶¶JulioPerez de la Serna##AnsPauwels∗∗∗Ana MariaLeguizamo‡‡‡Yeong YehLee‡§§§OsamuKawamura||||||JamalHayat¶¶¶AlbisHani‡‡‡SutepGonlachanvit###…C. PrakashGyawali∗
Baseline Predictors of Longitudinal Changes in Symptom Severity and Quality of Life in Patients With Suspected Gastroparesis
Allen A.Lee∗‡KrishnaRao§Henry P.Parkman‖Richard W.McCallum¶IreneSarosiek¶Linda A.Nguyen#John M.Wo∗∗Michael I.Schulman‡‡BaharakMoshiree§§SatishRao‖‖BradenKuo¶¶bWilliam L.Hasler∗b
Relationship Between Gastric Emptying Rate and Simultaneously Assessed Symptoms in Functional Dyspepsia
FlorenciaCarboneRowieDe BuysscherKarenVan den HouteJolienScholNickGoelenJanTack
Seroprevalence and Determinants of Helicobacter pylori Infection in the Hispanic Community Health Study/Study of Latinos
Sabrina H.Tsang∗M. LarissaAvilés-Santa‡Christian C.Abnet∗Maximo O.Brito§Martha L.Daviglus‖SylviaWassertheil-Smoller¶Sheila F.Castañeda#SharonMinnerath∗∗Gregory A.Talavera#Barry I.Graubard∗BharatThyagarajan∗∗M. ConstanzaCamargo∗
Effect of Domperidone Therapy on Gastroparesis Symptoms: Results of a Dynamic Cohort Study by NIDDK Gastroparesis Consortium
IreneSarosiek∗MarkVan Natta‡Henry P.Parkman§ThomasAbell||Kenneth L.Koch¶BradenKuo#Robert J.Shulman∗∗GianricoFarrugia‡‡MadhusudanGrover§§Frank A.Hamilton||||Pankaj J.Pasricha¶¶Katherine P.Yates‡LauraMiriel‡LauraWilson‡GoroYamada‡JamesTonascia‡Richard W.McCallum∗National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Gastroparesis Clinical Research Consortium (GpCRC)
Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients With Irritable Bowel Syndrome
AdrienneLenhart∗TienDong∗SwapnaJoshi∗‡NanceeJaffe∗CharleneChoo§CathyLiu∗‡Jonathan P.Jacobs∗‖VenuLagishetty∗WendyShih¶Jennifer S.Labus∗‡ArpanaGupta∗‡KirstenTillisch∗‡Emeran A.Mayer∗‡LinChang∗‡
Perianal Crohn’s Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN Cohort
OhadAtia∗NoaAsayag∗GiliFocht∗RonaLujan∗OrenLedder∗ShiraGreenfeld‡RevitalKariv‡IrisDotan§HagitGabay‖RanBalicer‖ZionaHaklai¶DanielNevo#DanTurner∗
Universal Immunohistochemistry for Lynch Syndrome: A Systematic Review and Meta-analysis of 58,580 Colorectal Carcinomas
Ellis L.Eikenboom∗‡aAnne-Sophievan der Werf–‘t Lam§aMarRodrÃguez-Girondo||Christi J.Van Asperen§Winand N.M.Dinjens¶Robert M.W.Hofstra∗Monique E.Van Leerdam#∗∗HansMorreau‡‡Manon C.W.Spaander‡AnjaWagner∗bMaartjeNielsen§b
Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study
Pedro L.S.UsonJr.∗DouglasRiegert-Johnson‡§‖LisaBoardman¶JohnKisiel¶LukeMountjoy∗NeejPatel#BlancaLizaola-Mayo#Mitesh J.Borad∗‖DanielAhn∗Mohamad B.Sonbol∗JeremyJones‖‖Jonathan A.Leighton#SuryakanthGurudu#HarminderSingh∗∗MargaretKlint§Katie L.Kunze‡‡Michael A.Golafshar‡‡Ed D.Esplin§§…NiloyJewel Samadder§‖#
Comorbidities Drive the Majority of Overall Mortality in Low-Risk Mucinous Pancreatic Cysts Under Surveillance
AnkitChhoda∗Muhammad N.Yousaf‡KamraanMadhani§HarryAslanian||Priya A.Jamidar||Alejandro L.Suarez||Ronald R.Salem¶ThiruvengadamMuniraj||John W.Kunstman¶James J.Farrell||
Age Dependence of Liver Enzymes: An Analysis of Over 1,300,000 Consecutive Blood Samples
DavidPetroff∗OlafBätz‡KatrinJedrysiak‡JanKramer‡ThomasBerg§JohannesWiegand§
Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis
NaotoFujiwara∗‡EricTrépo§||InduRaman¶Quan-ZhenLi¶DelphineDegré§||ThierryGustot§||ChristopheMoreno§||YujinHoshida∗
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores
AntonioDe Vincentis∗‡aFedericaTavaglione§||aOveisJamialahmadi||AntonioPicardi§RaffaeleAntonelli Incalzi∗LucaValenti¶#StefanoRomeo||∗∗‡‡bUmbertoVespasiani-Gentilucci§b
Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis
SaharTabatabavakili∗WesamAleyadeh∗OrlandoCerrocchi∗Harry L.A.Janssen∗Bettina E.Hansen∗‡Isaac I.Bogoch§Jordan J.Feld∗Viral Hepatitis Care Network Investigators
A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease
SeoilMoon∗¶∗Goh EunChung†¶∗Sae KyungJoo‡¶Jeong HwanPark§¶Mee SooChang§¶Ji WonYoon†¶Bo KyungKoo‖¶WonKim‡¶
Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation
ShuaiYuan∗DipenderGill‡§||¶Edward L.Giovannucci#∗∗‡‡Susanna C.Larsson∗§§
Association of Weight Changes With Changes in Histological Features and Blood Markers in Nonalcoholic Steatohepatitis
Dimitrios A.Koutoukidis∗‡Susan A.Jebb∗‡Jeremy W.Tomlinson‡§Jeremy F.Cobbold‡||PaulAveyard∗‡
Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network
FernandoBessone∗§§§aMirenGarcÃa-Cortés‡§§§aInmaculadaMedina-Caliz§§§§aNeliaHernandez‖RaymundoParana¶ManuelMendizabal#Maria I.Schinoni¶EzequielRidruejo∗∗ViniciusNunes¶MirtaPeralta‡‡GenarioSantos#MargaritaAnders§§DanielaChiodi‖MartinTagle‖‖PedroMontes¶¶EnriqueCarrera##MarcoArrese∗∗∗M. IsabelLizarzabal‡‡‡…Raúl J.Andrade‡§§§b
The Placebo Response in Randomized Trials in Nonalcoholic Steatohepatitis Simply Explained
Ian A.Rowe∗‡RichardParker‡
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults
JiayeLiu∗‡§IbrahimAyada§XiaofangZhang‖LingWang∗YangLi∗TianfuWen¶ZhongrenMa#Marco J.Bruno§Robert J.de Knegt§WanluCao§Maikel P.Peppelenbosch§MohsenGhanbari‖ZhihuiLi∗‡QiuweiPan§#
Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals
In YoungCho∗aYoosooChang‡§||aEunjuSung∗‡Jae-HeonKang∗HocheolShin∗‡Sarah H.Wild¶Christopher D.Byrne#∗∗SeunghoRyu‡§||
Population-Based Prevalence of Gastrointestinal Abnormalities at Colon Capsule Endoscopy
Fanny E.R.Vuik∗Stella A.V.Nieuwenburg∗SarahMoen∗Eline H.Schreuders∗Marinka D.Oudkerk Pool‡Elisabeth F.P.Peterse§CristianoSpada||¶OwenEpstein#IgnacioFernández-Urién∗∗AlbertHofman‡‡Ernst J.Kuipers∗Manon C.W.Spaander∗
The Next EPISOD: Trends in Utilization of Endoscopic Sphincterotomy for Sphincter of Oddi Dysfunction from 2010-2019
Zachary L.Smith∗‡RajShah∗B. JosephElmunzer§AmitabhChak∗
DCP and AFP-L3 Are Complementary to AFP in Predicting High-Risk Explant Features: Results of a Prospective Study
PrashantKotwaniWesleyChanFrancisYaoNeilMehta
Predicting Long-term Survival After Liver Transplantation in Patients With NASH Cirrhosis
Ravikiran S.Karnam∗‡NicholasMitsakakis§GiovannaSaracino‖LeslieLilly∗¶Sumeet K.Asrani‖MamathaBhat∗¶
Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease
Millie D.Long∗Corey A.Siegel‡Bincy P.Abraham§MichaelChiorean||UmaMahadevan¶
Defining the Long-Term Clinical Course and Need for Repeat Dilation for Patients With Schatzki Rings
Amrit K.Kamboj∗aSaamDilmaghani‡aBeth A.Schueler§John M.Barlow§David A.Katzka∗
Trends in the Prevalence of Metabolic Dysfunction–Associated Fatty Liver Disease in the United States, 2011–2018
Robert J.WongRamseyCheung
Vedolizumab for the Treatment of Noninflammatory Bowel Disease Related Enteropathy
Hisham J.Akhtar∗Tran M.Nguyen‡ChristopherMa‡‖VipulJairath∗‡¶
Diabetes Liver Fibrosis Score to Detect Advanced Fibrosis in Diabetics with Nonalcoholic Fatty Liver Disease
AmandeepSingh∗aRajatGarg‡aRocioLopez§||NaimAlkhouri¶
Characteristics of Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Sphincter of Oddi Disorders
Gregory A.Coté∗HaleyNitchie∗B. JosephElmunzer∗Richard S.Kwon‡Field F.Willingham§SachinWani||DanielMullady¶AmitabhChak#VikeshSingh∗∗AdamSlivka‡‡ShyamVaradarajulu§§MartinFreeman||||SrinivasGaddam¶¶PriyaJamidar##PaulTarnasky∗∗∗LydiaFoster‡‡‡Peter B.Cotton∗
Exam 1: Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults
Prevalence of Fatty Liver Disease is Driven by Prediabetes and Diabetes: US NHANES 2017–2018
KajalClaypoolPhD, MBIChirag J.PatelPhD
Private Practice Model for Inpatient GI Coverage at Tertiary Care Center: An Alternative to GI Hospitalist Service
VaibhavMehendirattaMDMichaelKarasikMDJeffryNestlerMD
Implicit Bias in Region-Dependent Publication Potential Can Partly be Counteracted by Academic Collaboration
Maikel P.PeppelenboschPHDCarmen V.FerreiraPHD
Defining Age-Related Thresholds for ALT and the Risk of Confounders
Daniel Q.HuangMBBS, MRCPMindie H.NguyenMD, MAS
Unanswered Questions About the Future Development of Gastroenterology Hospitalists
Daniel J.SteinMD, MPHRyanFlanaganMD, MPHKunalJajooMD
Combination Therapy of Immunomodulators With Non–Anti-Tumor Necrosis Factor Agents in Inflammatory Bowel Disease: Need More Evidence?
AvivPudipeddiMBBS (Hons), FRACPSudarshanParamsothyBSc (Med), MBBS (Hons 1), MRCP (UK), FRACP, PhDRupert W.LeongMBBS, FRACP, MD, AGAF
Advantage of Fecal MicroRNA Combination With Immunochemical Hemoglobin Test for Screening Colorectal Cancer
TomoyukiKawadaMD
